Author

Xin Wu

Observed names: X Wu, wu, xin

Institutions: Capital Medical University, Beijing Shijitan Hospital

Observed institutions: Shenyang Pharmaceutical University, Khon Kaen University, Capital Medical University, Chinese PLA General Hospital, Affiliated Hospital of Guizhou Medical University, The Affiliated Yongchuan Hospital of Chongqing Medical University, Peking University Third Hospital, Sun Yat-sen University Cancer Center, Beijing Shijitan Hospital, State Key Laboratory of Oncology in South China, Lead City University

ORCID: 0000-0002-8935-6075

Observed ORCID: 0000-0002-8935-6075

OpenAlex ID: A5013689462

Simultaneous determination of eight vitamin E isomers and α-tocopherol acetate in functional foods and nutritional supplements by gas chromatography – mass spectrometry

2015 · Dan Lu, Yi Yang, et al. · Analytical Methods · 20

Gas chromatography-triple quadrupole tandem mass spectrometry for successive single-surface migration study of phthalate esters from polythene film

2016 · Jinling Yang, Yongxin Li, et al. · Food Control · 18

Simultaneous Determination of 10 Adulterants in Antihypertensive Functional Foods Using Multi-Walled Carbon Nanotubes-Dispersive Solid-Phase Extraction Coupled with High Performance Liquid Chromatography

2015 · Li Zeng, Yongxin Li, et al. · Journal of Chromatographic Science · 15

Clinical Benefit of Avapritinib in KIT- Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies

2023 · Michael C. Heinrich, Xinhua Zhang, et al. · Clinical Cancer Research · 9

Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome

2015 · L Ma, Y Wang, et al. · Clinical & Experimental Immunology · 5

Paenibacillin A, a new 2(1H)-pyrazinone ring-containing natural product from the endophytic bacterium Paenibacillus sp. Xy-2

2015 · Xiqing Bian, Meili Shao, et al. · Natural Product Research · 5

Genomic diversity and surveillance of SARS-CoV-2 in Nigeria

2025 · Thomas J. Y. Kono, Ezenwa J. Onyemata, et al. · BMC Genomics · 1

Survival outcomes and prognostic factors of breast cancer spinal metastases: a retrospective study

2025 · Panpan Hu, Xin Wu, et al. · Discover Oncology · 1

[Prognosis and its influencing factors in patients with non-gastric gastrointestinal stromal tumors at low risk of recurrence: a retrospective multicenter study in China].

2024 · L X Yang, W L Yang, et al. · PubMed · 1

Integrating bioinformatics and machine learning to analyze drug resistance-associated biomarkers and immune cell infiltration characteristics in colorectal cancer

2026 · Wen Si, Shan Li, et al. · Discover Oncology

Long‐term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial

2025 · Jun Zhang, Yanqiao Zhang, et al. · Cancer

Ancient genomic evidence uncovers a 6th-century cross-border couple between South Asia and East Asia

2025 · Panxin Du, Yu Xu, et al. · Journal of Archaeological Science Reports

Is lymph node metastasis an advanced event of gastrointestinal stromal tumor?

2025 · Qi Jiang, Peng Zhang, et al. · The Oncologist

Data from Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies

2024 · Michael C. Heinrich, Xinhua Zhang, et al.

Supplementary Table S1 from Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies

2024 · Michael C. Heinrich, Xinhua Zhang, et al.

Supplementary Table S2 from Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies

2024 · Michael C. Heinrich, Xinhua Zhang, et al.

Data from Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies

2024 · Michael C. Heinrich, Xinhua Zhang, et al.

Supplementary Figure S1 from Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies

2024 · Michael C. Heinrich, Xinhua Zhang, et al.

Supplementary Table S1 from Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies

2024 · Michael C. Heinrich, Xinhua Zhang, et al.

Supplementary Figure S1 from Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies

2024 · Michael C. Heinrich, Xinhua Zhang, et al.

Supplementary Table S2 from Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies

2024 · Michael C. Heinrich, Xinhua Zhang, et al.

Comparison of Salmonella spp. Contamination and Antimicrobial Resistance Patterns between Two Pig Slaughterhouse Models

2019 · wu, xin, Angkititrakul, Sunpetch, et al. · KKU Veterinary Journal

Works count: 22

Citation count: 75

H-index: 5

I10-index: 3